1 October 16, 2004. 2 Secretary of the Department of Administration, Chair Director of the Public Employees Insurance Agency Secretary of the Department.

Slides:



Advertisements
Similar presentations
Journey Toward Financial Freedom Flora Digby And Sheila M. Wilkinson-Sanders Economic Development Chairs Phase II – Plan In Motion Income Taxes & Obama.
Advertisements

Optima Medicare (PPO) Plans CY Medicare Medicare is a Federal health insurance program for those age 65 or older or individuals at any age who have.
2 H.B. 4084, the Pharmaceutical Availability and Affordability Act, created the West Virginia Pharmaceutical Cost Management Council in W.Va. Code.
Chapter 2 - Working in Health Care McGraw-Hill © 2010 by The McGraw-Hill Companies, Inc. All rights reserved 2-1.
Stretching State Health Dollars in Difficult Economic Times: Pharmaceutical Purchasing Strategies Tanya Alteras Economic & Social Research Institute Families.
K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Figure 0 The Transition of Dual Eligibles to Medicare Drug Coverage: Implications for Beneficiaries.
Families USA Health Action Conference, 2010 State Opportunities in Health Reform Sonya Schwartz Program Director National Academy for State Health Policy.
THE COMMONWEALTH FUND Affordable Care Act of 2010: Major Provisions and Implementation Timeline Sara R. Collins, Ph.D. Vice President, Affordable Health.
The Impact of Drug Benefit Caps Geoffrey Joyce, PhD.
1 Survey of Retiree Health Benefits, 2007: A Chartbook Jon Gabel, Heidi Whitmore, and Jeremy Pickreign National Opinion Research Center September 2008.
The Introduction of National Health Insurance (Universal Health Care) in Saint Lucia Prepared by: Emma Hippolyte, Director, For ISSA meeting - BVI July.
New Jersey Election Law Enforcement Commission Pay-to-Play January 2013.
UNDERSTANDING HEALTH INSURANCE AND YOUR OPTIONS
Presented by the Illinois Department of Insurance Andrew Boron, Director November 2012.
Health care systems.
1 Medicare Part D Implementation North Dakotas Efforts.
Benefits of competition for low-income groups Andrey Tsyganov, Deputy Head of the FAS Russia FEDERAL ANTIMONOPOLY SERVICE Sofia Competition Forum November.
Federal Tort Claims Act (FTCA) Free Clinics Program Technical Assistance Call Department of Health and Human Services Health Resources and Services Administration.
Pharmacy Services Agreements Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 5/08/06.
Agenda Exchange Context Exchange 101 Implications for Employers
The Role of Medicaid in a Restructured Health Care System Cindy Mann Executive Director Center for Children and Families Georgetown University Health Policy.
Lafayette Parish School System Joint Meeting of the Board Insurance Committee & Employee Insurance Advisory Committee May 2006.
1. 2 West Virginia Beneficiaries by Enrollment Group Beneficiary Group Total Eligible % Eligible Elderly31, % Blind & Disabled 91, % Adults60, %
 Medicare Drug Rebates  Medicare patients who face a gap in prescription drug coverage would received a one-year, $250 rebate to help pay for medication.
Chapter 43 An Act Relative to Improving Accountability and Oversight of Education Collaboratives Presentation to Board of Elementary and Secondary Education.
Ideas for People Losing Illinois Cares Rx Benefits July 2011.
Maine Workers’ Compensation Medical Fee Schedule Maine Workers’ Compensation Board Office of Medical/Rehabilitation Services Presentation to the Maine.
April 14, 2004 Rod R. Blagojevich, Governor FDA Docket No. 2004N-0115 State of Illinois Canadian Drug Study FDA Docket No. 2004N-0115 Presented By: Ram.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
AREA AGENCY ON AGING AND DISABILITY STATE HEALTH INSURANCE ASSISTANCE PROGRAM (SHIP) 2012 Medicare 101.
Behavioral Health Board Chapter 31, Title 39 Idaho Code.
Minnesota Value Based Purchasing Susan McDonald Health Care Purchasing Coordinator Minnesota Department of Human Services Director Governor’s Health Cabinet.
Iowa Collaborative Safety Net Provider Network Pharmacy Initiative U of I School of Pharmacy Pharmaceutical Management For Underserved Population.
Part D Data Sharing Harry Gamble Office of Financial Management CMS.
March New Hampshire Retirement System. March Overview of Presentation  Structure and Governance  Plan Funding  Legislation  Important.
What Wonders Have They Wrought? The Patient Protection and Affordable Care Act.
H.R. 676 United States National Health Insurance Act or Expanded and Improved Medicare for All.
Karmen Hanson, MA Senior Policy Specialist National Conference of State Legislatures 340B Drug Purchasing: Options for States Overview of State Rx & 340B.
SC Workers’ Compensation Commission SC Hospital Association Managed Care Directors October 9, 2012.
Health Care Reform and its Impact on Michigan Janet Olszewski, Director Michigan Department of Community Health Senate Health Policy Committee May 5, 2010.
Kentucky Health Benefit Exchange FRYSCKy Fall Institute October 30, 2012 Miriam Fordham, Division Director Melea Rivera, Insurance Program Manger Office.
Spotlight on the Federal Health Care Reform Law. 2. The Health Care and Education Affordability Reconciliation Act of 2010 was signed March 30, 2010.
State Strategies: Expanding Prescription Drug Access Dee Mahan Families USA November 1, 2002.
Michigan Medicaid Pharmacy Cost Containment Paul Reinhart, Director Medical Services Administration Michigan Department of Community Health October 8,
Behavioral Health Board. As of July 1, 2014… Regional Behavioral Health Boards are established. The RAC and Mental Health Board will no longer exist.
1 Health Exchange Proposal Delaware Health Care Commission May 5, 2011.
The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.
Focus on the Drug Payment Methods Landscape Academy of Managed Care Pharmacy April 17, 2009.
IWIF Wellness Symposium John M. Colmers, Secretary Maryland Department of Health and Mental Hygiene June 8, 2010.
THE COMMONWEALTH FUND Figure 1. Medicare’s Success in Achieving Major Goals “How successful has Medicare been in accomplishing each of the following specific.
Status Report on Development of a Medicaid Preferred Drug List Program Presentation to: The Medicaid Pharmacy & Therapeutics Committee Cynthia B. Jones.
Regional Behavioral Health Boards Chapter 31, Title 39 Idaho Code.
Avalere Health LLC | The intersection of business strategy and public policy Medicare Prescription Drug Payment Presented by Margaret Nowak September 24,
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
© 2004 Moses & Singer LLP HIPAA and Patient Privacy Issues Raised by the New Medicare Prescription Drug Program National Medicare Prescription Drug Congress.
PRESENTATION TO PORTFOLIO COMMITTEE ON HEALTH PRICING REGULATIONS Presented by: Amos Masango, Acting Registrar South African Pharmacy Council 16 November.
Alliance for Health Reform Briefing: What’s in There? An Ask-the-Experts Overview of the Health Reform Law April 16, 2010 Dean A. Rosen, Partner
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Medicaid Influence in the Drug Market Dana Costea PhD student, Department of Economics, Lehigh University Franklin Carter Assistant Professor, Marketing.
MEDICATION USE IN RURAL AMERICA ASSOCIATION UPDATES National Community Pharmacists Association Tina Schlecht, PharmD, MBA Director, Pharmacy Affairs.
Financial Issues Chapter 14. Financial Issues Financial issues have a substantial influence on health care and pharmacy practice. In 1985 the average.
Chapter 5 Healthcare Reform. Objectives After studying this chapter the student should be able to: Describe the expansion of healthcare insurance under.
The Pharmacy Technician 4E
National Medicare Prescription Drug Congress
Will PBMs Participate in the New Medicare Prescription Drug Program
Medicare Reform: Implications for Pharmaceutical Manufacturers
Medicare Part D Implementation Issues: Key Decisions for States
Pharmacy Benefit Manager
Minnesota Board of Pharmacy
Presentation transcript:

1 October 16, 2004

2 Secretary of the Department of Administration, Chair Director of the Public Employees Insurance Agency Secretary of the Department of Health and Human Resources Commissioner of the Bureau of Medical Services (Medicaid) Commissioner of the Bureau for Senior Services Executive Director of the Workers Compensation Commission Licensed Pharmacist/Retail Pharmacy Representative Pharmaceutical Manufacturer with WV operations Primary Care Physician Representative of beneficiaries of the program Health Insurer with experience offering Rx coverage Membership

3 Evaluate clearinghouse, recommend state agency to own and operate Create Drug Discount Card Program Develop Reference Pricing Schedule and Strategic Plan for Implementation Evaluate the Financial Impact of the Medicare Prescription Drug Improvement and Modernization Act of 2003 on West Virginia Commence negotiations to for multi-state agreements Report to legislature national aggregate data on advertising marketing costs Mandatory Duties

4 Investigate purchase of Canadian drugs May pursue Federal Waivers May contract, may file suit May enter drug purchasing agreements with federal government, state agencies and subdivisions, other states and jurisdictions, large private sector purchasers Examine counter-detailing Explore disease-state management Explore licensing, continuing education, fees and procedures for drug- detailers Explore coordination of state payors Examine shared PDL among state payors/private purchasers Examine dispensing fees Discretionary Powers

5 Recommends which state agency to operate clearinghouse 09/01/04 Recommends pricing schedule/strategy for implementation 09/15/04 Report on fiscal impact of the MMA on the State10/15/04 Annual report (every year)12/31/04 Manufacturers financially support clearinghouse until12/31/04 Clearinghouse transferred from manufacturers to State 06/30/05 Pharmaceutical Council sunsets07/01/08 Pharmaceutical Council determines the ability to establish a savings of 42% of the retail cost no date Timeline

6 Recommends clearinghouse reside within the Department of Administration if State takes possession Recommends Cabinet Level Pharmacy Advocate Recommends central fill pharmacy as alternative to clearinghouse Clearinghouse Report

7 Recommends using the Federal Supply Schedule as a benchmark for negotiations Recommends uniform PDL and streamlined prior authorization process Recommends buying consortia which includes private sector Recommends Cabinet Level Pharmacy Advocate Recommends virtual pharmacy as a failsafe to protect local pharmacies Reference Pricing Report

pages of partial regulations released on August 3, 2004 Unclear how many WVians and how much WVians benefit from the Medicare Discount Cards Unclear how many retirees will have their Rx coverage dropped by their former employer Hospitals appear to benefit in the short-term Doctors are protected in the short-term but face cuts for Rx administration in the next years Rx Council will issue periodic reports on the MMA MMA Report

9 Status of State Discount Card 340b program review Detailing Status of Retail and Independent Pharmacies Other state agencies which purchase drugs Role of generic drugs Joint purchasing recommendations Pharmacy Collaborative Drug importation Office of the Pharmacy Advocate Annual Report

10 Passed by the House and Senate on November 16, 2004 Authorizes the Council to proceed with the recommendations of the Reference Pricing Report Concurrent Resolution

11 Signed by Governor Wise and Governor- elect Manchin on November 29, 2004 Creates the Cabinet Post of the Pharmaceutical Advocate Outlines the powers and responsibilities of the Pharmaceutical Advocate States that the post shall be filled by March 1, 2004 Executive Order 18-04

12 Pharmaceutical Council Website Shana Kay Phares Chair, Pharmaceutical Council Deputy Secretary, West Virginia Dept. of Health and Human Resources (304) Closing